Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retrospective Studies | 8 | 2024 | 2026 | 0.990 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 22 | 0.960 |
Why?
|
| Graft Survival | 1 | 2024 | 39 | 0.940 |
Why?
|
| Wet Macular Degeneration | 1 | 2023 | 3 | 0.930 |
Why?
|
| Homicide | 1 | 2023 | 15 | 0.920 |
Why?
|
| Pneumonia | 1 | 2024 | 54 | 0.920 |
Why?
|
| Medicaid | 2 | 2024 | 109 | 0.910 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 47 | 0.910 |
Why?
|
| Macular Degeneration | 1 | 2023 | 29 | 0.910 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 43 | 0.900 |
Why?
|
| Firearms | 1 | 2023 | 16 | 0.900 |
Why?
|
| Suicide, Attempted | 2 | 2024 | 91 | 0.900 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 28 | 0.890 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 86 | 0.880 |
Why?
|
| Alcoholism | 2 | 2023 | 240 | 0.840 |
Why?
|
| Infertility | 1 | 2022 | 18 | 0.830 |
Why?
|
| Suicide | 1 | 2023 | 118 | 0.820 |
Why?
|
| Hospitalization | 1 | 2024 | 388 | 0.760 |
Why?
|
| Maryland | 3 | 2024 | 53 | 0.710 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 560 | 0.680 |
Why?
|
| United States | 7 | 2024 | 4223 | 0.620 |
Why?
|
| Female | 12 | 2024 | 20969 | 0.520 |
Why?
|
| Humans | 18 | 2024 | 37093 | 0.480 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.410 |
Why?
|
| Adult | 8 | 2024 | 11712 | 0.390 |
Why?
|
| Male | 8 | 2024 | 20025 | 0.350 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 208 | 0.250 |
Why?
|
| Gastric Bypass | 1 | 2024 | 17 | 0.230 |
Why?
|
| Incidence | 2 | 2024 | 922 | 0.230 |
Why?
|
| Carcinoma, Medullary | 1 | 2023 | 1 | 0.230 |
Why?
|
| Cesarean Section | 1 | 2024 | 55 | 0.230 |
Why?
|
| Retina | 2 | 2023 | 280 | 0.230 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 31 | 0.230 |
Why?
|
| Cicatrix | 1 | 2023 | 17 | 0.230 |
Why?
|
| Mediastinal Emphysema | 1 | 2023 | 1 | 0.230 |
Why?
|
| Pregnancy Outcome | 1 | 2024 | 87 | 0.230 |
Why?
|
| Pneumothorax | 1 | 2023 | 9 | 0.230 |
Why?
|
| Social Class | 2 | 2022 | 247 | 0.220 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2023 | 59 | 0.220 |
Why?
|
| Visual Acuity | 1 | 2023 | 97 | 0.220 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2023 | 36 | 0.220 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 1067 | 0.220 |
Why?
|
| Inpatients | 1 | 2023 | 74 | 0.220 |
Why?
|
| Cause of Death | 1 | 2023 | 156 | 0.220 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 68 | 0.220 |
Why?
|
| Developed Countries | 1 | 2022 | 12 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 29 | 0.210 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 39 | 0.210 |
Why?
|
| Registries | 1 | 2024 | 335 | 0.210 |
Why?
|
| Population Surveillance | 1 | 2023 | 238 | 0.210 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 494 | 0.200 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 37 | 0.200 |
Why?
|
| Middle Aged | 3 | 2024 | 10129 | 0.200 |
Why?
|
| Residence Characteristics | 1 | 2024 | 322 | 0.200 |
Why?
|
| Infant, Newborn | 1 | 2024 | 894 | 0.190 |
Why?
|
| Internship and Residency | 1 | 2022 | 125 | 0.190 |
Why?
|
| Violence | 1 | 2022 | 134 | 0.190 |
Why?
|
| Poverty | 1 | 2023 | 348 | 0.180 |
Why?
|
| Pregnancy | 1 | 2024 | 1549 | 0.160 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 2379 | 0.160 |
Why?
|
| Quality of Life | 1 | 2022 | 481 | 0.150 |
Why?
|
| Prevalence | 1 | 2022 | 1455 | 0.150 |
Why?
|
| Risk Factors | 2 | 2023 | 3562 | 0.150 |
Why?
|
| Obesity | 2 | 2023 | 1067 | 0.150 |
Why?
|
| Young Adult | 2 | 2024 | 4268 | 0.150 |
Why?
|
| Adolescent | 2 | 2024 | 5363 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 730 | 0.130 |
Why?
|
| SEER Program | 2 | 2023 | 91 | 0.110 |
Why?
|
| Aged | 1 | 2024 | 6741 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2024 | 210 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1502 | 0.100 |
Why?
|
| Disease Progression | 2 | 2022 | 601 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 23 | 0.060 |
Why?
|
| Tracheostomy | 1 | 2023 | 4 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 16 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2023 | 45 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 55 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 441 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 290 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 182 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 739 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 268 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2024 | 1369 | 0.040 |
Why?
|